Corporate Strategy

Bionest Partners provides strategic analyses and recommendations to help create, develop or revisit company-wide strategies.  Our experience covers the entire company (e.g.; assessing new businesses, new geographies, attractiveness of diversification, strategic segmentation, etc.) as well as selected functions (e.g.; commercial, scientific, manufacturing, administrative, etc.) needing to address strategic questions, such as organizational effectiveness.

We have a unique corporate strategy consulting suite, encompassing full-fledged strategic analysis up to, and including, financial evaluations of strategic options (e.g.; valuation, comparables, P&L, balance sheet and cash clows).

Clinical strategy in humans and animals for     an oncology start-up company  Commercial launch of a service company spun out from     a big pharma  Strategic positioning of a CMO and recommendation  Securing the corporate development of a vaccine business  Consideration of Entry in Europe to leverage     partnering negotiations  Due diligence in Animal Health for CEVA acquired by     ABN Amro  Due diligence in Diagnostics for ABN Amro to acquire     AES Laboratories